Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
41.34
-0.42 (-1.01%)
At close: May 12, 2026

Sunshine Lake Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
482.711,99376.6-587.65
Depreciation & Amortization
395.66391.27377.36259.82
Loss (Gain) From Sale of Assets
-10.330.530.8219.07
Asset Writedown & Restructuring Costs
86.52485.39288.8425.98
Loss (Gain) From Sale of Investments
1.79-4.39-522.7-19.24
Loss (Gain) on Equity Investments
-0.6-0.22--
Stock-Based Compensation
89.9745.14--
Other Operating Activities
-129.95165.311,084136.21
Change in Accounts Receivable
-200.63-1,418-530.59-216.1
Change in Inventory
-236.88-94.02-35.3398.57
Change in Accounts Payable
-388.85109.49961.31-379.18
Operating Cash Flow
89.421,6731,700-662.51
Operating Cash Flow Growth
-94.66%-1.57%--
Capital Expenditures
-968.3-343.72-570.07-356.29
Sale of Property, Plant & Equipment
35.76-0.950.03
Sale (Purchase) of Intangibles
-213.8-251.36-283-223.4
Investment in Securities
-9.62,579-290-
Other Investing Activities
1,244-1,43021.95140.55
Investing Cash Flow
88.26554.57-1,120-439.11
Long-Term Debt Issued
1,5212,164517.94444.96
Long-Term Debt Repaid
-1,862-3,454-1,146-157.68
Total Debt Repaid
-1,862-3,454-1,146-157.68
Net Debt Issued (Repaid)
-340.61-1,290-628.22287.28
Other Financing Activities
-107.7-186.63-158.8-99.8
Financing Cash Flow
-448.31-1,477-787.03187.48
Foreign Exchange Rate Adjustments
-0-0.01-0.30.29
Net Cash Flow
-270.64750.87-207.58-913.85
Free Cash Flow
-878.891,3291,130-1,019
Free Cash Flow Growth
-17.67%--
Free Cash Flow Margin
-23.60%21.12%30.17%-111.49%
Free Cash Flow Per Share
-3.795.734.87-4.39
Cash Interest Paid
93.42138.32112.7499.8
Cash Income Tax Paid
238.82230.49255.43-18.62
Levered Free Cash Flow
-93.311,067-2,703-616.5
Unlevered Free Cash Flow
-32.361,209-2,527-464.12
Change in Working Capital
-826.35-1,402395.39-496.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.